Effects of Atomoxetine on Cognitive Function in Schizophrenia

Clinical trial NCT00420498 · COMPLETED

Trial details

NCT number: NCT00420498
Sponsor: Yale University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Cognition Smoking

Start date: 2005-08-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.